ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

NCI Director’s Office Gets Makeover In Reorganization Plan.

December 8, 2006

Pain Relievers Protect Against Breast Cancer

April 25, 2003

Letter To the Editor; Closed Meetings Create Aura of Suspicion

August 12, 1994

Drug Discovery Group Announcement Issued

January 7, 1983